carvedilol has been researched along with fluorodeoxyglucose f18 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hanatani, A; Hirooka, K; Ishida, Y; Komamura, K; Miyatake, K; Nakatani, S; Yamagishi, M; Yasumura, Y | 1 |
Akabuogu, EU; Phyu, SM; Smith, TA | 1 |
El Darazi, E; Goldman, S; Muteganya, R; Tsechelidis, I; Weyts, K | 1 |
3 other study(ies) available for carvedilol and fluorodeoxyglucose f18
Article | Year |
---|---|
Improvement in cardiac function and free fatty acid metabolism in a case of dilated cardiomyopathy with CD36 deficiency.
Topics: Adrenergic beta-Antagonists; Adult; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; CD36 Antigens; Fatty Acids; Fatty Acids, Nonesterified; Fluorodeoxyglucose F18; Heart Function Tests; Humans; Iodobenzenes; Male; Propanolamines; Radionuclide Imaging; Radiopharmaceuticals | 2000 |
Effects of Administered Cardioprotective Drugs on Treatment Response of Breast Cancer Cells.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carbazoles; Cardiomyopathies; Cardiotonic Agents; Cardiovascular Agents; Carvedilol; Cell Line, Tumor; Cell Survival; Dexrazoxane; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Enalapril; Female; Fluorodeoxyglucose F18; Humans; Metformin; Propanolamines; Radionuclide Imaging; Radiopharmaceuticals; Receptor, ErbB-2; Trastuzumab | 2016 |
Failure of Classical β-Blocker Carvedilol to Deactivate Brown Adipose Tissue in a Patient With Pheochromocytoma.
Topics: Adipose Tissue, Brown; Adrenal Gland Neoplasms; Adrenergic beta-Antagonists; Adult; Carbazoles; Carvedilol; Female; Fluorodeoxyglucose F18; Humans; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Propanolamines; Treatment Failure | 2018 |